Sutro Biopharma, Inc.

STRO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$57-$11-$76-$72
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$5$6$6
Change in WC$5-$51-$9-$16
Other Non-Cash$12$10$10$9
Operating Cash Flow-$38-$45-$68-$72
Investing Activities
PP&E Inv.-$0-$0-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$90-$29-$142-$126
Inv. Sales/Matur.$130$31$127$215
Other Inv. Act.$0$0$0$0
Investing Cash Flow$40$3-$16$87
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$0-$0
Financing Cash Flow$0-$0$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$42-$84$16
Supplemental Information
Beg. Cash$64$107$191$175
End Cash$66$65$107$191
Free Cash Flow-$38-$45-$69-$73
Sutro Biopharma, Inc. (STRO) Financial Statements & Key Stats | AlphaPilot